Trial · NCT01588353
Results by group13
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 13 of 13
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| The Percentage of Participants That Were Successfully Treated With a Successful Reduction in Contracture to 5°or Less | AK160 0.58 mg Step 1-2 | 86 | % Participants | ||
| Clinical Improvement After the Last Injection | Primary MP Joints | 100 | 95% Confidence Interval 92.5 to 100.0 | % Participants | |
| Clinical Improvement After the Last Injection | Primary PIP Joints | 90.0 | 95% Confidence Interval 73.5 to 97.9 | % Participants | |
| Clinical Improvement After the Last Injection | Total | 96.1 | 95% Confidence Interval 89.0 to 99.2 | % Participants | |
| Percent Reduction From Baseline Contracture After the Last Injection | Primary MP Joints | 97.08 | Standard Deviation 7.791 | % of change from baseline | |
| Percent Reduction From Baseline Contracture After the Last Injection | Primary PIP Joints | 82.48 | Standard Deviation 24.674 | % of change from baseline | |
| Percent Reduction From Baseline Contracture After the Last Injection | Total | 91.39 | Standard Deviation 17.900 | % of change from baseline | |
| Change From Baseline Range of Motion After the Last Injection | Primary MP Joints | 41.6 | Standard Deviation 18.91 | Degrees | |
| Change From Baseline Range of Motion After the Last Injection | Primary PIP Joints | 33.3 | Standard Deviation 17.73 | Degrees | |
| Change From Baseline Range of Motion After the Last Injection | Total | 38.4 | Standard Deviation 18.79 | Degrees | |
| Time to First Achieve and Maintain Clinical Success After the Last Injection | Primary MP Joints | 1.0 | Inter-Quartile Range 1.0 to 28.0 | Days | |
| Time to First Achieve and Maintain Clinical Success After the Last Injection | Primary PIP Joints | 7.0 | Inter-Quartile Range 1.0 to 92.0 | Days | |
| Time to First Achieve and Maintain Clinical Success After the Last Injection | Total | 1.0 | Inter-Quartile Range 1.0 to 30.0 | Days |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01588353/results